Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Christopher Ogden

CFO at CytomX Therapeutics, Inc. (CTMX)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $129K

Reported trades

Filed Stock Type Shares Price Value Since
Jun 17SEC CTMXCytomX Therapeutics, Inc. Sell 1,624295,324 held (−1%) $3.05 $5K -25.2%
Mar 19SEC CTMXCytomX Therapeutics, Inc. Sell 19,323296,948 held (−6%) $6.42 $124K -64.5%